Cargando…

Advances in Heparins and Related Research. An Epilogue

Detalles Bibliográficos
Autores principales:	Fareed, Jawed, Bacher, Peter, Jeske, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017696/ https://www.ncbi.nlm.nih.gov/pubmed/29439508 http://dx.doi.org/10.3390/molecules23020390

Ejemplares similares

Editorial Epilogue
por: Lahiri, Koushik
Publicado: (2017)

Porcine Mucosal Heparin Shortage Crisis! What Are the Options?
por: Fareed, Jawed, et al.
Publicado: (2019)

Waiting for Godot – Epilogue
por: James, James J.
Publicado: (2020)

Epilogue
Publicado: (1891)

Epilogue
por: Dolan, Elizabeth M.
Publicado: (2020)

Epilogue
por: Krossa, Anne Sophie
Publicado: (2020)

Epilogue
por: Yeung, Sharon
Publicado: (2021)

Epilogue
por: Vallath, Nandini, et al.
Publicado: (2021)

Epilogue
por: Janowski, Andrew
Publicado: (2021)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Epilogue of Texas Life
por: Lee, Sangkook
Publicado: (2012)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins
por: Kouta, Ahmed, et al.
Publicado: (2019)

Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin
por: Olson, Guy, et al.
Publicado: (2023)

Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

An epilogue to an emergency-trauma practicum
por: Hong, Allen Eugene
Publicado: (2017)

Cooperative Research and Infectious Disease Surveillance: A 2021 Epilogue
por: Parekh, Falgunee K., et al.
Publicado: (2022)

Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels
por: Jeske, Walter, et al.
Publicado: (2019)

SIT for African malaria vectors: Epilogue
por: Townson, Harold
Publicado: (2009)

Epilogue: The Language Opportunities for the 21st Century
por: Pitts, Margaret J.
Publicado: (2020)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates
por: Kouta, Ahmed, et al.
Publicado: (2020)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Comparative Pharmacokinetic Profile of 3 Batches of Ovine Low-Molecular-Weight Heparin and 1 Batch of Branded Enoxaparin
por: Jeske, Walter, et al.
Publicado: (2018)

Epilogue: Technology Acceleration Intersects the Thirty Years’ Crisis
por: Gvosdev, Nikolas
Publicado: (2020)

Epilogue: Lessons from the CONVERGE study of major depressive disorder in China
por: Flint, Jonathan, et al.
Publicado: (2012)

Epilogue: Reflections from International Mentors of the Quality Improvement Training Programme in India
por: Lorenz, Karl, et al.
Publicado: (2021)

The Risk of Venous Thromboembolism is Not Equal for all Patients Who Undergo Total Joint Replacement
por: Tafur, Alfonso, et al.
Publicado: (2019)

Peering into the future: long-run economic and social consequences of automation; with an epilogue on COVID-19
por: Prettner, Klaus, et al.
Publicado: (2020)

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
por: Jeske, Walter, et al.
Publicado: (2013)

To heparinize or not to heparinize: Effect on arterial blood gas measurements
por: Lobo, Valentine
Publicado: (2014)

Introduction to the Molecules Special Edition Entitled ‘Heparan Sulfate and Heparin: Challenges and Controversies’: Some Outstanding Questions in Heparan Sulfate and Heparin Research
por: Yates, Edwin A, et al.
Publicado: (2019)

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants
por: Mendes, Aline, et al.
Publicado: (2019)

Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates
por: Kouta, Ahmed, et al.
Publicado: (2021)

Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19
por: Marchetti, Giulia, et al.
Publicado: (2023)

Surviving Covid-19 with Heparin?
por: ten Cate, Hugo
Publicado: (2021)

Epilogue: Reflections from Stakeholders of a Facilitated Community Partnership Developed to Provide Palliative Care to a Vulnerable Population in Kerala
por: Thelly, Anu Savio Savio, et al.
Publicado: (2023)

Research Advances in Age-Related Macular Degeneration
por: Abdolrahimzadeh, Solmaz
Publicado: (2022)

Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy
por: Gupta, Yash, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ae3ovohpam68vsd8anucj6rqb